SEC Form 4 · accession 0001209191-16-126592
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Vaughn
Officer — Chief Commercial Officer
Period of report
Jun 6, 2016
Accepted (ET)
Jun 8, 2016 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 6, 2016 | M | 1,997 | $18.89 | A | 34,076 | D | |
| Common StockF1,F2,F3 | Jun 6, 2016 | S | 1,997 | $28.00 | D | 32,079 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $18.89 | Jun 6, 2016 | M | 1,997 | D | — | Nov 30, 2016 | Common Stock | 1,997 | 0 | D |
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on September 9, 2015.
- F2Represents actual sale price.
- F3Includes an aggregate of 18,280 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F4The option became exercisable as to 25% of the shares on November 30, 2007, and became exercisable as to 1/48th of the shares each full month thereafter.